Basepair™ Joins the AWS Partner Network
New York, New York – May 10, 2023 – Basepair™, innovator of the point and click bioinformatics solution that facilitates organization-wide collaboration between bench scientists and bioinformaticians, announced today that it has successfully completed the Amazon Web Services (AWS) Foundational Technical Review (FTR) and has joined the AWS Partner Network (APN).
The FTR is administered by AWS and helps AWS Partners identify AWS Well-Architected best practices specific to their software or solution as established by the AWS Well-Architected Framework for aspects such as security, operational excellence, and sustainability.
Basepair’s CEO, Amit Sinha, commented “Successful completion of the AWS FTR is further validation of our platform’s ability to meet AWS best practices related to reliability, cost optimization and performance efficiency. We are delighted to expand our relationship with AWS to empower organizations to leverage the compute and storage resources in their own accounts when taking a platform approach to Bioinformatics.”
This news follows the company’s recent announcement that access to the platform may be procured in AWS Marketplace, making it even easier to access pay-as-you-go point & click industry standard tools across a multitude of application areas including Genomics, Epigenetics, Transcriptomics and others. “The deepening of our relationship with AWS recognizes the widespread adoption of their technology by our customers and our desire to make our solutions as accessible as possible” said Simon Valentine, Chief Commercial Officer at Basepair. “Becoming an AWS Partner provides our customers with the peace of mind that Basepair’s platform on AWS is fully vetted and utilizes AWS services efficiently to deliver market-leading bioinformatics solutions.”
For more information, visit the Basepair™ website and our AWS Marketplace listing.
About Basepair™
Basepair™ Inc is the market leader in helping organizations maximize the potential of their own cloud, personnel and genomic data resources to accelerate time to scientific insight in the biopharmaceutical, academic and genomic technologies industries. The easy-to-use interface, modern architecture, and novel pay-as-you-go licensing model enables scientists in organizations of all types and sizes to quickly analyze and make sense of a multitude of genomic data types, expedite the scientific discovery that leads to novel therapeutics and life-saving medicines. See for yourself just how easy it is to use by trying it for free or schedule a demo below.